The Healthcare and Macro-Economic Impacts of Living with Endemic COVID – Listening to Fitch
Health Populi
JUNE 24, 2021
The third chart details some of these points: On the macroeconomic side of the forecast, we see increasing private consumption, higher inflation, less public sector support (e.g., For Medicare Part B programs alone, the drug could consume one-half of the total $57 billion of medicines spending… as much as the U.S. spends on NASA.
270 
Let's personalize your content